Cataracts are an extremely common condition, often described as the lens of the eye gradually becoming cloudy, much like a camera lens covered in frost. This clouding leads to symptoms such as blurred or dimmed vision, fading colors, difficulty seeing at night, and increased sensitivity to glare. When cataracts progress, they can significantly impact independence, making routine activities like driving or reading a struggle.

While managing early symptoms with stronger glasses or anti-glare lenses can help temporarily, cataracts are a physical change to the lens that cannot be reversed by diet or corrective lenses alone. Treatment is necessary to restore sharp vision and prevent further loss of function. Because a cataract is a physical opacity, the only definitive solution is surgery. Medications, therefore, play a vital, supporting role by preparing the eye for the procedure, ensuring a complication-free surgery, and promoting optimal healing (National Eye Institute, 2023).

Overview of treatment options for Cataract

The main goal of cataract treatment is to remove the cloudy, natural lens and replace it with a clear, artificial lens (called an intraocular lens, or IOL). This surgical procedure is the most common approach and is highly successful.

Medications are typically used in the context of this procedure. They address four main areas: pre-operative preparation, infection prevention, pain management, and inflammation control. Although there is ongoing research into “anti-cataract” eye drops designed to slow or reverse lens clouding, these are not yet approved or recommended as standard curative treatments. Thus, pharmacologic treatment focuses almost entirely on supporting the surgical process.

Medications used for Cataract

Medications for cataracts fall into distinct classes used immediately before or after surgery:

  • Pre-operative Drops (Mydriatics): Before the procedure, doctors use powerful drops to dilate the pupil. Common examples include tropicamide and phenylephrine. These drops ensure the surgeon has adequate visibility to safely access the cloudy lens.
  • Post-operative Antibiotics: To prevent the risk of a serious eye infection, a course of topical antibiotics is prescribed. Medications in the fluoroquinolone class (such as moxifloxacin or gatifloxacin) are frequently used.
  • Post-operative Anti-inflammatory Drugs: Swelling and discomfort are normal after surgery. Treatment involves two main types of drops:
    • Corticosteroids: These steroid drops (e.g., prednisolone or dexamethasone) are highly potent and rapidly reduce inflammation.
    • NSAID Drops: Non-steroidal anti-inflammatory drugs (e.g., ketorolac or nepafenac) provide sustained pain and inflammation relief, often used alongside or after steroids.

Relief from visual blurring due to the cataract itself is instantaneous following a successful surgery, but final visual clarity depends on the successful control of post-operative inflammation by these prescribed medications.

How these medications work

These supportive medications work on various structures of the eye to ensure a smooth surgical experience and recovery.

Mydriatic drops work on the iris muscles, forcing the pupil to open wide. This provides the surgeon with a clear window through which to perform the delicate procedure.

Antibiotic drops work by killing any bacteria that may have been present on the eye’s surface or introduced during the surgery. This preventative measure is critical, as severe post-operative infections can be vision-threatening.

Anti-inflammatory drops, both steroids and NSAIDs, work by suppressing the natural immune response to trauma. Cataract removal is a minimally invasive procedure, but it still triggers inflammation. These medications block chemical messengers that cause swelling and pain, allowing the eye structures to heal quickly and properly. Clinical guidelines confirm that adherence to these drop regimens significantly minimizes post-operative complications (American Academy of Ophthalmology, 2024).

Side effects and safety considerations

Eye drops rarely cause serious systemic side effects, but temporary local effects like stinging, redness, or a bitter taste may occur. Steroid anti-inflammatory drops need monitoring for a temporary spike in intraocular pressure, possibly requiring dosage adjustment.

Antibiotic drops pose a low allergy risk. Dilating drops cause temporary light sensitivity (photophobia) and focusing difficulty. Patients should seek immediate medical attention for sudden, worsening pain, severe redness, or rapid vision loss post-surgery.

Since everyone’s experience with the condition and its treatments can vary, working closely with a qualified healthcare provider helps ensure safe and effective care.

References

  1. American Academy of Ophthalmology. https://www.aao.org
  2. Mayo Clinic. https://www.mayoclinic.org
  3. National Eye Institute. https://www.nei.nih.gov
  4. National Institutes of Health. https://www.nih.gov

Medications for Cataract

These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Cataract.

Found 6 Approved Drugs for Cataract

Ketorolac Tromethamine

Brand Names
Sprix, Toronova, Ketorocaine, Strenza, Toronova SUIK, Acuvail, Acular

Ketorolac Tromethamine

Brand Names
Sprix, Toronova, Ketorocaine, Strenza, Toronova SUIK, Acuvail, Acular
Ketorolac tromethamine ophthalmic solution is indicated for the reduction of ocular pain and burning/stinging following corneal refractive surgery. Ketorolac tromethamine ophthalmic solution is a nonsteroidal, anti-inflammatory drug (NSAID) indicated for the reduction of ocular pain and burning/stinging following corneal refractive surgery. ( 1 )

Bromfenac

Brand Names
Prolensa, Bromsite

Bromfenac

Brand Names
Prolensa, Bromsite
Bromfenac ophthalmic solution.

Omidria

Generic Name
Ketorolac

Omidria

Generic Name
Ketorolac
Omidria ® is added to an ocular irrigating solution used during cataract surgery or intraocular lens replacement and is indicated for maintaining pupil size by preventing intraoperative miosis and reducing postoperative ocular pain. OMIDRIA is an alpha 1-adrenergic receptor agonist and nonselective cyclooxygenase inhibitor indicated for: Maintaining pupil size by preventing intraoperative miosis ( 1 ) Reducing postoperative pain ( 1 ) OMIDRIA is added to an ocular irrigating solution used during cataract surgery or intraocular lens replacement.

Nepafenac

Brand Names
Ilevro, Nevanac

Nepafenac

Brand Names
Ilevro, Nevanac
ILEVRO ® 0.3% is indicated for the treatment of pain and inflammation associated with cataract surgery. ILEVRO ® 0.3% is a nonsteroidal, anti-inflammatory prodrug indicated for the treatment of pain and inflammation associated with cataract surgery ( 1 ).

Alcaine

Generic Name
Proparacaine

Alcaine

Generic Name
Proparacaine
Proparacaine hydrochloride ophthalmic solution is indicated for topical anesthesia in ophthalmic practice. Representative ophthalmic procedures in which the preparation provides good local anesthesia include measurement of intraocular pressure (tonometry), removal of foreign bodies and sutures from the cornea, conjunctival scraping in diagnosis and gonioscopic examination; it is also indicated for use as a topical anesthetic prior to surgical operations such as cataract extraction.
Showing 1-5 of 6
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances